Related references
Note: Only part of the references are listed.Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation
M. Mielcarek et al.
BLOOD (2016)
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease
Nicolaus Kroeger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning
Junichi Sugita et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
Yvette L. Kasamon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Loss of Lymph Node Fibroblastic Reticular Cells and High Endothelial Cells Is Associated with Humoral Immunodeficiency in Mouse Graft-versus-Host Disease
Fumiko Suenaga et al.
JOURNAL OF IMMUNOLOGY (2015)
Bone Marrow Graft-versus-Host Disease: Evaluation of Its Clinical Impact on Disrupted Hematopoiesis after Allogeneic Hematopoietic Stem Cell Transplantation
Yusuke Shono et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans
Ryan Flynn et al.
BLOOD (2014)
Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans
Mathangi Srinivasan et al.
BLOOD (2012)
Thymic T-cell development in allogeneic stem cell transplantation
Werner Krenger et al.
BLOOD (2011)
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius
Gerard Socie et al.
BLOOD (2011)
Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation
John R. Wingard et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Alloimmune Response Results in Expansion of Autoreactive Donor CD4+ T Cells in Transplants That Can Mediate Chronic Graft-versus-Host Disease
Dongchang Zhao et al.
JOURNAL OF IMMUNOLOGY (2011)
Salivary Gland Involvement in Chronic Graft-Versus-Host Disease: Prevalence, Clinical Significance, and Recommendations for Evaluation
Matin M. Imanguli et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation
Yusuke Shono et al.
BLOOD (2010)
Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice
Shoji Asakura et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease
Il-Kang Na et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation
Paul J. Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Molecular signature of CD8+ T cell exhaustion during chronic viral infection
E. John Wherry et al.
IMMUNITY (2007)
CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease
Yi Zhang et al.
JOURNAL OF IMMUNOLOGY (2007)
Chronic GvHD decreases antiviral immune responses in allogeneic BMT
Mohammad S. Hossain et al.
BLOOD (2007)
Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease
Yukimi Sakoda et al.
BLOOD (2007)
Maintenance of memory CD8(+) T cell diversity and proliferative potential by a primary response upon re-challenge
Makoto Kurachi et al.
INTERNATIONAL IMMUNOLOGY (2007)
Stimulation history dictates memory CD8 T cell phenotype: Implications for prime-boost vaccination
David Masopust et al.
JOURNAL OF IMMUNOLOGY (2006)
Host-reactive CD8+ memory stem cells in graft-versus-host disease
Y Zhang et al.
NATURE MEDICINE (2005)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Donor APCs are required for maximal GVHD but not for GVL
CC Matte et al.
NATURE MEDICINE (2004)
Target antigens determine graft-versus-host disease phenotype
DH Kaplan et al.
JOURNAL OF IMMUNOLOGY (2004)
Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1α (CCL3) after allogeneic BMT in mice
A Panoskaltsis-Mortari et al.
BLOOD (2003)
Share Paper
